Mapping the research landscape of nanotechnology based immunotherapy for hepatocellular carcinoma

Bibo Peng; Ruijiang Li; Guohai Xu; Lianggeng Gong; Liangxia Xiong

doi:10.1007/s12672-025-04164-w

Affiliated Institutions

Related Publications

Molecular therapies and precision medicine for hepatocellular carcinoma

Josep M. Llovet , Robert Montal , Daniela Sia +1 more

The global burden of hepatocellular carcinoma (HCC) is increasing and might soon surpass an annual incidence of 1 million cases. Genomic studies have established the land...

2018 Nature Reviews Clinical Oncology 1909 citations

Hepatocellular carcinoma

Arndt Vogel , Tim Meyer , Gonzalo Sapisochín +2 more

Hepatocellular carcinoma is one of the most common cancers worldwide and represents a major global health-care challenge. Although viral hepatitis and alcohol remain important r...

2022 The Lancet 1910 citations

Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features

Julien Caldéraro , Benoı̂t Rousseau , Giuliana Amaddeo +9 more

The prognosis of hepatocellular carcinoma (HCC) remains poor, with only one third of patients eligible for curative treatments and very limited survival benefits with the use of...

2016 Hepatology 430 citations

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

Anthony B. El-Khoueiry , Bruno Sangro , Thomas Yau +18 more

2017 The Lancet 4168 citations

Advances in immunotherapy for hepatocellular carcinoma

Bruno Sangro , Pablo Sarobe , Sandra Hervás‐Stubbs +1 more

Hepatocellular carcinoma (HCC) is a prevalent disease with a progression that is modulated by the immune system. Systemic therapy is used in the advanced stage and until 2017 co...

2021 Nature Reviews Gastroenterology & Hep... 1220 citations

Publication Info

Year: 2025
Type: article
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Mapping the research landscape of nanotechnology based immunotherapy for hepatocellular carcinoma

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Bibo Peng, 
                                
                                    Ruijiang Li, 
                                
                                    Guohai Xu
                                
                                et al.
                            
                            (2025). 
                            Mapping the research landscape of nanotechnology based immunotherapy for hepatocellular carcinoma. 
                            Discover Oncology
                            
                            .
                            https://doi.org/10.1007/s12672-025-04164-w

Identifiers

DOI: 10.1007/s12672-025-04164-w